FDA recall D-1486-2014

Boehringer Ingelheim Roxane Inc · Class III · drug

Product

OXYCODONE HYDROCHLORIDE C II Oral Solution USP, 5 mg/5 mL, 15 mL Vial, Rx only. Boehringer Ingelheim, Roxane Laboratories. Roxane Laboratories, Inc. Columbus, Ohio 43216. NDC: 0054-0523-41.

Reason for recall

Failed Stability Specifications: Out of specification result for preservative sodium benzoate.

Distribution

U.S. Nationwide

Key facts

Status
Terminated
Initiation date
2014-07-28
Report date
2014-08-06
Termination date
2015-05-29
Voluntary/Mandated
Voluntary: Firm initiated
Location
Columbus, OH, United States

Primary source

https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-1486-2014